TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All News
of of All News
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>CCI Approves Restructuring: Haleon Acquires GSK Consumer Healthcare via Demerger; GSK and Pfizer Hold Voting Rights.</h1> The Competition Commission of India has approved the corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings Limited, involving its acquisition by Haleon through a demerger and share exchange. Post-restructuring, Haleon's voting rights will be held by GSK and its affiliates (68%) and Pfizer (32%). GSK is a global pharmaceuticals company, while Pfizer is a biopharmaceutical firm. Haleon, a newly formed entity, currently has no business activities. The restructuring involves the legacy consumer healthcare businesses of GSK and Pfizer, initially combined in 2019. A detailed order from the CCI is forthcoming.
TaxTMI 
TaxTMI 
